Saturday, August 09, 2008

TauRx Therapeutics-- New treatment halts progress of Alzheimer's disease

The results of the Phase 2 study of TauRx's new treatment strongly suggest that it is possible to halt progression in mild and moderate Alzheimer's. TauRx is continuing to refine its treatment and hopes that restoration may be possible at least at the earlier stages with improved versions of its drug. Tangles are already destroying nerve cells in parts of the brain critical for memory in people in their fifties and upwards. The ultimate goal is to develop a product that is convenient for patients that could be widely used at the very earliest stages of the disease, long before patients experience the first symptoms of Alzheimer's.
blog it

Tuesday, December 18, 2007

Start-Up Sells Solar Panels at Lower-Than-Usual Cost

clipped from
Nanosolar, a heavily financed Silicon Valley start-up whose backers include Google’s co-founders, plans to announce Tuesday that it has begun selling its innovative solar panels, which are made using a technique that is being held out as the future of solar power manufacturing.
The company, which has raised $150 million and built a 200,000-square-foot factory here, is developing a new manufacturing process that “prints” photovoltaic material on aluminum backing, a process the company says will reduce the manufacturing cost of the basic photovoltaic module by more than 80 percent.
Nanosolar, which recently hired a top manufacturing executive from I.B.M., said that it had orders for its first 18 months of manufacturing capacity. The photovoltaic panels will be made in Silicon Valley and in a second plant in Germany.
Nanosolar has focused on lowering the manufacturing cost
claims to be the first solar panel manufacturer to be able to
sell solar panels for less than $1 a watt

blog it